✓Market closed - Last update: Nov 13, 2026, 4:41 PM ET
⚡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Market closed · Next open: Monday 9:30 AM ET
Last update: Nov 13, 2026, 6:17 PM ETMarket closed·75 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Market closed - Last update: Nov 13, 2026, 4:39 PM ET
🛡Material / Earnings✓High confidence
What changed: Rivian Automotive, Inc. (RIVN) moved -5.14% from $12.84 to $12.18 on 2026-11-13. Despite positive news — UBS initiated a $17 price target citing R2 SUV breakthrough and improving margins, and Rivian reported 38% YoY revenue growth in Q3 with expanded Amazon and potential Walmart delivery van partnerships — the stock declined on elevated cash burn of $1.12 billion in the quarter.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
RIVN earnings scheduled for 2026-02-11, with consensus EPS estimate of -$0.55; cash burn trend and updated guidance will be critical.
✓Market closed - Last update: Nov 13, 2026, 4:39 PM ET
⚡Material / Earnings✓High confidence
What changed: Ionis Pharmaceuticals, Inc. (IONS) moved +6.45% from $27.30 to $29.06 on November 13, 2026, the same day the company presented long-term efficacy data for DAWNZERA (donidalorsen) in hereditary angioedema at ACAAI 2026. This occurred amid significant headwinds: Ionis had recently slashed full-year TRYNGOLZA sales guidance by ~50% after Q3 sales reached only $9.3 million, and a law firm initiated an investor investigation into potential securities claims.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
IONS earnings scheduled for February 24, 2027 (date not yet confirmed), with consensus EPS estimate of −$1.35.
✓Market closed - Last update: Nov 13, 2026, 4:39 PM ET
⚡Material / Earnings✓High confidence
What changed: Dutch Bros Inc. (BROS) moved +7.26% from $33.47 to $35.90 on November 13, 2026, rebounding after a sharp multi-day sell-off triggered by its early-November earnings release. The bounce was driven by value-seeking investors viewing the stock as oversold relative to its long-term cash flow and revenue trajectory, despite cautious fourth-quarter and full-year margin guidance. Dutch Bros continues to post strong top-line growth (around 30% year-over-year revenue increases) and is executing a plan to open 250 new shops by 2027.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Dutch Bros earnings scheduled for February 11, 2027 (consensus EPS estimate $0.18) will be critical to track margin trajectory and store-opening execution against guidance.
✓Market closed - Last update: Nov 13, 2026, 4:39 PM ET
🛡Material / Earnings✓High confidence
What changed: DigitalOcean Holdings, Inc. (DOCN) moved -5.11% from $90.97 to $86.32 on 2026-11-13. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting the move was not driven by unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for DOCN earnings on 2027-02-23 (date not yet confirmed) to assess whether results align with the $0.32 EPS consensus.
✓Market closed - Last update: Nov 13, 2026, 4:39 PM ET
🛡Material / Earnings✓High confidence
What changed: Allegro MicroSystems, Inc. (ALGM) moved -5.49% from $31.88 to $30.13 on 2026-11-13. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific negative catalyst was found. The decline appears to be profit-taking following a sharp 7-day rally of roughly 18.3%, with volume near its 5-day average indicating consolidation rather than capitulation.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Earnings scheduled for 2026-02-02 with consensus EPS estimate of $0.26 will be the next major catalyst for the stock.
✓Market closed - Last update: Nov 13, 2026, 4:39 PM ET
🛡Material / Earnings✓High confidence
What changed: Tempus AI, Inc. (TEM) moved -5.41% from $75.65 to $71.56 on 2026-11-13. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move occurred on volume near its 5-day average, suggesting routine trading rather than event-driven selling.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor earnings announcement on 2026-02-23 for actual results versus the $0.06 EPS consensus estimate.
✓Market closed - Last update: Nov 13, 2026, 4:38 PM ET
🛡Material / Earnings✓High confidence
What changed: Vertiv Holdings Co (VRT) moved -5.16% from $213.06 to $202.07 on 2026-11-13. We checked news, earnings, analyst updates, and filings — no company-specific catalyst was found on or immediately before this date. The decline occurred on volume near its 5-day average, suggesting modest selling pressure without a clear trigger.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
VRT earnings scheduled for 2026-02-10 will test whether AI and data center demand sustains the 61% growth rate and supports the raised full-year guidance.
✓Market closed - Last update: Nov 13, 2026, 4:38 PM ET
🛡Material / Earnings✓High confidence
What changed: ATI Inc. (ATI) moved -5.02% from $192.77 to $183.09 on November 13, 2026, the day after its Investor Day presentation. Management outlined a $7 billion revenue target by 2029 with sustained growth beyond that, alongside capacity investments in nickel powder and zirconium sponge targeting double-digit growth and margin expansion. The decline followed a classic "buy the rumor, sell the news" pattern, as the stock had rallied over 50% year-to-date into the event on the strength of a Q3 earnings beat and raised guidance in late October.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
ATI earnings scheduled for February 2, 2027, with consensus EPS estimate of $1.56.
✓Market closed - Last update: Nov 13, 2026, 4:38 PM ET
🛡Material / Earnings✓High confidence
What changed: Sterling Infrastructure, Inc. (STRL) moved -5.90% from $310.73 to $292.39 on 2026-11-13. We checked news, earnings, analyst updates, filings, and corporate actions — no company-specific catalyst was found. Volume was near its 5-day average, suggesting a technical pullback rather than a major news-driven event.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
STRL earnings are scheduled for 2027-02-24, with consensus EPS estimate at $4.82.
✓Market closed - Last update: Nov 13, 2026, 9:32 AM ET
Intraday updates3 updates
3:50 PM ETLATESTValuation✓ High confidence
Modine Manufacturing surged 28.41% to $136.25 following Bloomberg reports that Samsung Electronics is in discussions to acquire the data center cooling specialist in a deal valued around $5.6 billion. Samsung is seeking Modine as a strategic asset to strengthen its AI infrastructure footprint, where liquid and thermal cooling for high-density processors is a critical bottleneck. Volume spiked to 4.88M shares, 7.25x the time-adjusted average, reflecting elevated investor interest.
11:20 AM ETActivity✓ High confidence
Modine Manufacturing surged 25.66% to $133.32 after invezz.com reported Samsung's surprise takeover interest in the company, citing AI cooling demand as a strategic driver. Volume reached 4.35 million shares, trading at 8.51x the time-adjusted expected level, signaling institutional accumulation around the potential acquisition.
10:51 AM ETValuation✓ High confidence
Samsung Electronics is in discussions to acquire Modine Manufacturing in a potential deal valued around $5.6 billion, according to Bloomberg reporting cited in the web catalyst. The acquisition would position Samsung to deepen its presence in AI infrastructure and high-density processor cooling — a critical bottleneck in data center buildout. MOD surged +27.13% to $134.88 on elevated volume of 3.6M shares (10.79x expected for this time of day), reversing a 15% decline from early November when the company reported higher production costs and margin pressures.
+2 earlier updates — view all in Changes History ↓
▤
Changes History →Related research: Modine (MOD) Surges ~31% on a Report Samsung Is in Talks to Buy It →
What's next
What to watch
Monitor for official deal announcements or regulatory filings; Modine's analyst and investor day on November 18, 2026 may provide management commentary on strategic discussions or updated financial guidance.
✓Market closed - Last update: Nov 13, 2026, 9:32 AM ET
Intraday updates3 updates
3:50 PM ETLATESTValuation✓ High confidence
Cerebras Systems surged 8.24% to $105.80 following a strong Q3 2026 earnings beat, raised full-year revenue guidance, and announcement of a new cloud infrastructure deal with Microsoft, per Reuters and Invezz. The AI chipmaker reported record Q3 GAAP revenue of $210.8M and posted its first quarterly adjusted profit as a public company, projecting annual revenue will triple in 2027.
10:15 AM ETActivity✓ High confidence
Cerebras Systems reported better-than-expected earnings and raised its annual forecast today, while announcing a new deal with Microsoft, according to Reuters and invezz.com. The stock surged +10.50% from $97.75 to $108.02 in early trading. The profit surprise and guidance increase appear to have eased investor concerns about AI spending deceleration in the sector.
10:10 AM ETActivity✓ High confidence
Cerebras Systems filed an 8-K material event disclosure today alongside its earnings report, driving an 11.36% intraday gain to $108.86 (from $97.75 close). The specific content of the 8-K filing was not detailed in available sources, but material event disclosures typically signal significant business developments, partnerships, or strategic announcements.
+2 earlier updates — view all in Changes History ↓
▤
Changes History →Related research: Cerebras (CBRS) Jumps ~7% on a Q3 Beat and a Hyperscaler Deal, Bucking the AI Selloff →
What's next
What to watch
Monitor Q4 2026 revenue trends and execution updates on the Microsoft deal deployment; track any analyst upgrades or price-target revisions in the coming days.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
Stock AnalysisNovember 13, 2026 · 12 min read
Nvidia (NVDA) Slides as Jensen Huang Abruptly Resigns as CEO, Days Before Earnings
NVIDIA fell about 3% to roughly $161 on November 13, slipping back below a $4 trillion market value, as the market digested a sudden and unexpected leadership change: co-founder Jensen Huang has resigned as President, CEO and board member, effective immediately. The Board named longtime CFO Colette Kress interim CEO and appointed Harvey C. Jones as its first-ever Chair, while launching a search for a permanent chief. NVIDIA's transition release gave no reason; days earlier, Mr. Huang had acknowledged an affair and the board had launched an independent investigation into a reported foreign-intelligence targeting (ongoing and unproven), and lawmakers have since sought his testimony. Because NVIDIA anchors the entire AI trade, the turmoil added to an already fragile tape — AMD fell ~10.5%, Broadcom ~5.4% and the semis ETF ~4%, versus less than 1% for the S&P 500. The timing is delicate: NVIDIA reports fiscal Q3 (FY2027) results on November 17, so one of tech's most closely watched prints will be delivered by an interim CEO days into an unexpected leadership transition. The franchise looks intact — ~$303B trailing revenue, ~20x earnings — so the sell-off reads as a repricing of leadership and governance risk rather than any newly reported operating weakness.
NVDARead →
Stock AnalysisNovember 13, 2026 · 12 min read
Cerebras (CBRS) Jumps ~7% on a Q3 Beat and a Hyperscaler Deal, Bucking the AI Selloff
Cerebras Systems rose about 7% to roughly $104.50 on November 13 after reporting third-quarter results — and what made it notable was the backdrop: the same day, the broader AI and chip trade sold off hard, with Nvidia down 3.5%, the semiconductor ETF down more than 4% and AMD down about 10%. For a richly valued AI name to rise while its sector cratered is a clear sign the move was its own news. Cerebras — maker of dinner-plate-sized 'wafer-scale' chips built to challenge Nvidia — beat its own guidance for a third straight quarter, raised its full-year outlook, flagged a cloud deal with a top-three hyperscaler (unnamed in the release, reportedly Microsoft) and projected revenue will triple in 2027, with a $26 billion backlog. But the quarter must be read carefully: the most flattering numbers are non-GAAP. Cerebras highlights 'core' revenue up 70% to about $231 million and a core net profit near $30 million, but on a GAAP basis revenue rose 55% to $210.8 million and the company posted a $161 million net loss. The gap is real — 'core' revenue is higher than GAAP because it adds back customer-warrant amortization, and the 'core' profit excludes heavy stock compensation. The company is cash-rich (about $7.8 billion), so financing is not the worry, but it is deeply GAAP-unprofitable, heavily reliant on a few customers including OpenAI, and trades near 30 times sales. Even bullish analysts cut their targets on the print (UBS to about $155), while keeping Buy ratings. A strong quarter bought a day of outperformance in a weak tape — but the hardest questions about the business are still open.
CBRSRead →
Stock AnalysisNovember 13, 2026 · 11 min read
Modine (MOD) Surges ~31% on a Report Samsung Is in Talks to Buy It
Modine Manufacturing surged about 31% to roughly $139 on November 13 after Bloomberg reported the day before that Samsung Electronics is in talks to acquire the company — a maker of the thermal and liquid cooling systems that keep AI data centers from overheating. The appeal is strategic: as AI chips run hotter, data-center cooling has become a critical bottleneck, and Modine has reinvented itself into a focused, fast-growing pure-play, separating its legacy business (combining it with Gentherm) in October while data-center sales jumped about 95% in its most recent quarter. But the crucial point is what this is not: it is not a deal. Bloomberg's report says the talks could come together in weeks but that no final decision has been made, the discussions could fall through, and another buyer could emerge — and no offer price, terms or premium have been reported, with neither company confirming. The widely cited $5.6 billion figure is essentially Modine's market value before the report, not an agreed price, and the stock has already jumped above that level, to about $7.4 billion, as traders price in a premium that has not been offered. The move was company-specific: cooling peers were flat to lower, with the sector leader Vertiv actually down, so there is no read-through to competitors. Analysts rated the stock Strong Buy even before the report, though their targets were cut sharply after a fiscal Q2 earnings miss and predate any deal. In short, the surge is real but rests on a report, not terms; from here the stock trades as a bet on the outcome of private talks.
MODRead →
Stock AnalysisNovember 11, 2026 · 11 min read
CoreWeave (CRWV) Jumps ~25% on a Q3 Beat, Raised Guidance and a $133B Backlog
CoreWeave jumped about 25% to roughly $61 on November 11 after reporting a blowout third quarter the evening before. Revenue rose 168% to about $3.7 billion, above the high end of guidance, and the company raised its full-year outlook while reporting a record $133 billion revenue backlog. For the purest public play on the AI-infrastructure buildout — it rents Nvidia GPUs to the largest AI developers — it was emphatic proof that demand is not the problem. The more important shift was on the other question hanging over the stock: financing. CoreWeave is building a GPU empire on borrowed money, posting a $709 million net loss driven by $846 million of quarterly interest expense, with $14.5 billion of capital spending in the quarter and $37–$39 billion guided for the year. The stock had fallen more than 50% from its high on exactly those worries, so what sparked the rally was management addressing them — a shift toward contract-matched debt and customer prepayments, a lower cost of borrowing, and a path to adjusted profitability by 2028. Still, the balance sheet remains the defining feature: enterprise value near $95 billion against a roughly $33 billion equity value, the gap some $66 billion of debt. Tellingly, even as the stock soared, several analysts cut their price targets hard — from $176 to $100, from $100 to $45 — a sign the demand question is answered but the financing math still has to play out. The move led the AI-infrastructure complex and far outpaced the chip sector, marking it as company-specific.
CRWVRead →
Stock AnalysisNovember 10, 2026 · 11 min read
Hims & Hers (HIMS) Drops ~18% as Q3 Gross Margin Craters on the GLP-1 Shift
Hims & Hers fell about 18% to roughly $18.76 on November 10 — a seven-month low — after third-quarter results that grew revenue 49% to about $890 million but exposed a margin problem underneath. Gross margin collapsed to about 57% from 74% a year earlier, the company swung to a $33 million GAAP net loss (about $0.14 a share, versus a profit expected) even as adjusted EBITDA stayed positive, and it cut its full-year adjusted-EBITDA guidance to roughly $257–$277 million, from $275–$325 million — its third reduction this year. The culprit is the same thing that made HIMS a market darling: weight-loss drugs. As the era of cheap compounded GLP-1 medications wound down, Hims pivoted to selling branded drugs, which are a low-margin, pass-through business, so the mix shift that keeps revenue growing — led by its international rollout — is compressing margins. (A just-announced deal to distribute Eli Lilly's Zepbound, unveiled after the quarter closed, lifted the stock Friday but postdates these results.) Subscribers also disappointed, rising 13% to about 2.79 million but below the roughly 3.04 million expected and down about 100,000 sequentially, with management flagging more weakness. The move was company-specific: telehealth peers were roughly flat, the market barely moved, and Eli Lilly, the drug supplier, actually rose. Wall Street is lukewarm — a Hold consensus, with brokers cutting targets toward the mid-$20s on the print, though still above the price. After a 50%-plus decline the stock trades at under two times sales, which looks cheap only if margins and subscribers stabilize — the very things that just deteriorated.
HIMSRead →
Stock AnalysisNovember 9, 2026 · 12 min read
QXO (QXO) Jumps ~20% as the TopBuild Deal Lifts Q3 Sales 79%
QXO jumped about 20% to roughly $13.90 on November 9 after the building-products distributor released preliminary third-quarter results ahead of its full report. Net sales rose about 79% to $4.9 billion and adjusted EBITDA rose about 85% to $557 million, with the margin edging up to 11.4% — modestly ahead of the roughly $4.85 billion revenue consensus. QXO is the building-products roll-up of Brad Jacobs, who previously built XPO Logistics and United Rentals, and this was its first full quarter including TopBuild, the insulation installer and distributor it bought on July 1 for about $15 billion. So the 79% sales jump is mostly acquired, not organic — the scale of acquisitions landing in the numbers for the first time, though management pointed to improving organic sales trends and firmer pricing on a separate call. What the market rewarded was the margin signal — EBITDA growing faster than sales as a giant deal is absorbed — the clearest early sign the integration is working, against a stock that had fallen roughly 19% over the past year. The caveats are important: these are preliminary, unaudited figures (full results come November 12); the growth is acquisition-driven and the release gave no consolidated organic rate; QXO is still a GAAP loss-maker because of acquisition amortization, interest and deal costs; and the expansion is financed with heavy share issuance (the count is up about 60% in a year) and roughly $7 billion of debt. The move was company-specific — QXO far outpaced building-products peers that rose only mid-single digits. Analysts keep a Strong Buy with an average target near $24, though several had trimmed targets into the quarter. The real verdict waits for the full results.
QXORead →